Apixaban During Atrial Fibrillation Catheter Ablation: Comparison to Vitamin K Antagonist Therapy
- Status
- COMPLETED
- Phase
- PHASE4
Clinical Trials Related to Bristol-Myers Squibb
Related studies linked through entity extraction aliases.
Phase 1b/2, Open Label, Repeat Dose, Dose Escalation Study of ND-L02-s0201 Injection in Subjects With Moderate to Extensive Fibrosis (METAVIR F3-4)
- Status
- COMPLETED
- Phase
- PHASE1
A Phase 1 Drug-drug Interaction Study in Healthy Volunteers
- Status
- COMPLETED
- Phase
- PHASE1
YERVOY® Risk Minimization Tool Effectiveness Evaluation Survey
- Status
- COMPLETED
- Phase
- N/A
Study of Combined Ionizing Radiation and Ipilimumab in Metastatic Non-small Cell Lung Cancer (NSCLC)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Belatacept 3 Month Post Transplant Conversion Study
- Status
- COMPLETED
- Phase
- PHASE4
Suicidality and Suicide Attempt Among HIV Patients on Efavirenz-containing Versus Efavirenz-free Antiretroviral Regimens
- Status
- COMPLETED
- Phase
- N/A
A Randomized, Placebo-Controlled, Double-Blind, Single Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BMS-986104 in Healthy Male Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Multiple Ascending Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetics of BMS-986120 in Healthy Subjects and the Effects of Co-Administration of Midazolam and BMS-986120
- Status
- COMPLETED
- Phase
- PHASE1
Adjuvant Therapy of Completely Resected Merkel Cell Carcinoma With Immune Checkpoint Blocking Antibodies vs Observation
- Status
- COMPLETED
- Phase
- PHASE2
Expanded Access Program With Nivolumab in Combination With Ipilimumab in Patients With Tumors Unable to be Removed by Surgery or Metastatic Melanoma
- Status
- NO_LONGER_AVAILABLE
- Phase
- N/A
Study of Nivolumab in Patients With Classical Hodgkin's Lymphoma (Registrational)
- Status
- COMPLETED
- Phase
- PHASE2
Apixaban in Patients With Sickle Cell Disease
- Status
- TERMINATED
- Phase
- PHASE3
Short Duration Combination Therapy With Daclatasvir, Asunaprevir, BMS-791325 and Sofosbuvir in Subjects Infected With Chronic Hepatitis-C (FOURward Study)
- Status
- COMPLETED
- Phase
- PHASE2
Study of Drug Combination on Pharmacokinetics in Healthy Volunteers
- Status
- COMPLETED
- Phase
- PHASE1
A Phase 3 Study of a Daclatasvir/Asunaprevir/BMS-791325 Fixed Dose Combination (FDC) in Subjects With Chronic Hepatitis C Genotype 1
- Status
- COMPLETED
- Phase
- PHASE3
Post-marketing Study Assessing the Long-Term Safety of Abatacept
- Status
- COMPLETED
- Phase
- N/A
Study to Determine the Effect of Efavirenz on the ECG QTcF Interval in Healthy Subjects
- Status
- COMPLETED
- Phase
- PHASE1
A Multicenter Treatment Protocol of Daclatasvir (BMS-790052) in Combination With Sofosbuvir for the Treatment of Post-Liver Transplant Subjects With Chronic Hepatitis C
- Status
- NO_LONGER_AVAILABLE
- Phase
- N/A
A Study of Subcutaneous Abatacept to Treat Diffuse Cutaneous Systemic Sclerosis
- Status
- COMPLETED
- Phase
- PHASE2